Indivior Pharmaceuticals, Inc. (INDV) Balance Sheet
As of 2026-06-30 (10-Q), Indivior Pharmaceuticals, Inc. (INDV) reported total assets of $1.2B, total liabilities of $1.4B and shareholders' equity of -$208.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $222.0M. Long-term debt: $487.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
INDVIndivior Pharmaceuticals, Inc.Follow INDV — free
—
Price chart with a free account
- Market cap
- 4.1B
- P/E TTM
- 12.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.10 | 0.77 | 0.32 | 0.32 | 0.20 | 0.22 | |
| Short-term investments | — | — | 0.09 | 0.00 | 0.00 | — | |
| Receivables | — | — | 0.25 | 0.25 | 0.25 | 0.27 | |
| Inventory | — | — | 0.13 | 0.17 | 0.15 | 0.15 | |
| Current assets | 1.44 | 1.26 | 1.26 | 0.83 | 0.65 | 0.73 | |
| Total assets | 1.83 | 1.77 | 1.76 | 1.32 | 1.20 | 1.23 | |
| Current liabilities | 0.80 | 1.02 | 1.28 | 0.92 | 0.91 | 0.87 | |
| Long-term debt | 0.24 | 0.24 | 0.24 | 0.32 | 0.29 | 0.49 | |
| Short-term debt | 0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | |
| Total liabilities | 1.63 | 1.72 | 1.94 | 1.65 | 1.30 | 1.44 | |
| Shareholders' equity | 0.12 | -0.02 | -0.18 | -0.34 | -0.10 | -0.21 |
USD billions · SEC XBRL
Indivior Pharmaceuticals, Inc. — questions
- How much cash does Indivior Pharmaceuticals, Inc. have?
- $222.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does Indivior Pharmaceuticals, Inc. have?
- $487.0M of long-term debt and $0 due within a year as of 2026-06-30.
- What are Indivior Pharmaceuticals, Inc.'s total assets?
- $1.2B as of 2026-06-30.
- What is Indivior Pharmaceuticals, Inc.'s shareholders' equity?
- -$208.0M as of 2026-06-30.
Every figure on this page comes from Indivior Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.